Cargando…
Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients
On the 30(th) of January 2020, the World Health Organization fired up the sirens against a fast spreading infectious disease caused by a newly discovered Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and gave this disease the name COVID-19. While there is currently no specific treatme...
Autores principales: | Itani, Rasha, Tobaiqy, Mansour, Al Faraj, Achraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254986/ https://www.ncbi.nlm.nih.gov/pubmed/32483428 http://dx.doi.org/10.7150/thno.46691 |
Ejemplares similares
-
siRNA Conjugated Nanoparticles—A Next Generation Strategy to Treat Lung Cancer
por: Itani, Rasha, et al.
Publicado: (2019) -
The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19
por: Daou, Farah, et al.
Publicado: (2021) -
Shedding Light on the Direct and Indirect Impact of the COVID-19 Pandemic on the Lebanese Radiographers or Radiologic Technologists: A Crisis within Crises
por: Itani, Rasha, et al.
Publicado: (2021) -
Correlation of Kidney Size on Computed Tomography with GFR, Creatinine and HbA1C for an Accurate Diagnosis of Patients with Diabetes and/or Chronic Kidney Disease
por: Ghaith, Nashaat, et al.
Publicado: (2021) -
Recent strategies to design vascular theranostic nanoparticles
por: Gupta, Mukesh K., et al.
Publicado: (2017)